BiotechTube
Lattice Automation

Lattice Automation

Boston, United States· Est.
latticeautomation.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $4M

Overview

Lattice Automation is a specialized software development studio serving the biotech industry, particularly in synthetic biology. It provides custom software development, proprietary tools/libraries, and workflow integration services, acting as an embedded engineering partner for clients. Founded by academic synthetic biology automation expert Doug Densmore, the company leverages deep domain expertise to build mission-critical software that avoids vendor lock-in. Its business model is services-based, generating revenue through client engagements while also developing open-source and licensed tools.

AI / Machine LearningSynthetic Biology

Technology Platform

A suite of custom software development expertise, reusable libraries, and tools for synthetic biology, including DNA sequence visualization (SeqViz), Python libraries for assembly automation, and repository-based plasmid design algorithms. Focus on full-stack development, workflow integration, and bio-design automation.

Funding History

1
Total raised:$4M
Seed$4M

Opportunities

The rapid growth of synthetic biology and increasing lab automation create massive demand for specialized software that generic tools cannot meet.
Lattice's deep domain expertise and partnership model position it to capture high-value projects from companies lacking internal bio-software engineering resources.
The expansion of AI/ML in biology presents a further opportunity to develop and integrate advanced predictive design and analysis tools into client workflows.

Risk Factors

Revenue is dependent on a project-based services model, which is less scalable and more susceptible to client budget cycles than a product business.
Competition is emerging from both in-house biotech software teams and larger commercial bioinformatics platforms.
The company's success is critically tied to recruiting and retaining a rare blend of top-tier software engineering and molecular biology talent.

Competitive Landscape

Lattice competes with internal software teams at large biotechs, generic software consulting firms lacking biology expertise, and a growing number of venture-backed synthetic biology SaaS platforms (e.g., Benchling, TetraScience, Riffyn). Its key differentiator is its deep, academic-rooted expertise in bio-design automation and its commitment to building owned, in-house software for clients without vendor lock-in, a contrast to the subscription-based platform model of many competitors.

More companies in Digital Health & Biotech SaaS →More companies in United States →